Patient-Generated Medication Histories in Complex Care: Clinical Relevance, Challenges, and Future Directions

Abstract

Accurate medication histories are crucial for safe and effective patient care, particularly in complex care environments where polypharmacy and comorbidities are common. Increasingly, patient-generated medication histories (PGMH) are being leveraged to improve medication reconciliation, reduce errors, and enhance clinical decision-making. This review synthesizes current evidence on the utility, challenges, and clinical implications of PGMH in complex care, examining epidemiology, risk factors, diagnostic challenges, and recent advances. Recommendations for integrating PGMH into routine care, based on recent guidelines and emerging research, are also discussed to inform best practices for healthcare professionals.

Introduction

Medication discrepancies remain a leading cause of preventable adverse events in healthcare, particularly among patients with complex medical needs. While traditional medication reconciliation relies on provider-collected histories, the integration of patient-generated medication histories has gained attention as a strategy to enhance accuracy and patient engagement. This article critically reviews the scientific foundations, clinical relevance, and practical considerations of PGMH in complex care, providing an evidence-based resource for clinicians navigating the challenges of medication management in high-risk populations.

Epidemiology / Disease Burden

Complex care patients typically defined as individuals with multiple chronic conditions, frequent healthcare encounters, and extensive medication regimens represent a significant proportion of healthcare utilization and expenditures. Studies indicate that up to 60% of hospitalized patients have at least one medication discrepancy at admission, with higher rates observed in those with polypharmacy. Adverse drug events (ADEs) attributable to medication errors are estimated to account for over 700,000 emergency department visits and 100,000 hospitalizations annually in the United States alone. In this context, accurate and comprehensive medication histories are essential for mitigating risk and optimizing patient outcomes.

Pathophysiology

Medication discrepancies arise from multiple sources: fragmented care transitions, incomplete records, cognitive impairment, health literacy barriers, and communication breakdowns between providers and patients. In complex care, polypharmacy increases the risk of drug-drug interactions, therapeutic duplications, and omissions. The pathophysiological consequences include suboptimal disease control, adverse events, and exacerbation of comorbidities, particularly in vulnerable populations such as the elderly or those with renal or hepatic impairment. Mechanistically, the failure to capture accurate medication histories undermines pharmacovigilance and patient safety.

Risk Factors

Key risk factors for medication discrepancies in complex care include advanced age, cognitive dysfunction, low health literacy, language barriers, frequent transitions of care, and the use of multiple prescribers or pharmacies. Social determinants, such as limited access to healthcare resources and lack of caregiver support, further compound these risks. Patients with complex regimens involving high-risk medications such as anticoagulants, insulin, or immunosuppressants are particularly susceptible to clinically significant errors.

Clinical Features

Clinically, medication discrepancies may manifest as unexplained symptoms, suboptimal therapeutic response, or new adverse events. In the inpatient setting, discrepancies are often detected during medication reconciliation at admission or discharge, but may also be uncovered during outpatient follow-up or via pharmacist-led interventions. Features suggestive of incomplete or inaccurate medication histories include inconsistencies between patient reports and pharmacy records, undocumented over-the-counter or herbal product use, and unexplained clinical deterioration.

Diagnosis

The diagnosis of medication discrepancies hinges on systematic medication reconciliation, incorporating data from multiple sources: patient self-report, caregiver input, pharmacy dispensing records, and electronic health records (EHR). Structured tools and checklists, such as the MARQUIS (Multi-Center Medication Reconciliation Quality Improvement Study) toolkit, have been developed to standardize the process. Patient-generated medication histories, obtained through validated questionnaires, digital platforms, or patient portals, are increasingly recognized as a valuable adjunct to provider-driven methods, particularly when cross-referenced with objective data.

Treatment & Management

Effective management of medication discrepancies involves prompt identification, root cause analysis, and reconciliation in collaboration with patients, caregivers, pharmacists, and prescribers. Incorporating PGMH into routine workflows can enhance this process by capturing critical details about medication adherence, recent changes, and non-prescription product use. Interdisciplinary team-based approaches, supported by EHR integration and clinical decision support, facilitate comprehensive review and documentation. Ongoing education for patients and providers on the importance of accurate medication lists is essential for sustaining improvements.

Recent Advances / Emerging Therapies

Recent advances in health information technology have enabled scalable approaches to capturing PGMH. Mobile health applications, patient portals, and digital medication management tools allow patients to actively update and share their medication information in real time. Artificial intelligence and natural language processing are being explored to reconcile discrepancies and flag potential interactions. Pilot studies demonstrate that PGMH-driven interventions can reduce medication errors, improve adherence, and enhance patient satisfaction, though challenges in standardization and interoperability remain.

Guideline Recommendations

Recent guidelines from the Joint Commission and professional societies emphasize the centrality of medication reconciliation in patient safety, advocating for patient engagement as a core component. Best practice recommendations include the use of standardized medication history forms, integration of patient-reported data with provider documentation, and leveraging health IT to support bidirectional communication. Organizations such as the Institute for Healthcare Improvement (IHI) and World Health Organization (WHO) endorse patient-centered approaches, highlighting the role of PGMH in reducing adverse events and improving care transitions.

Conclusion

Patient-generated medication histories represent a pivotal innovation in the management of complex care, offering a means to enhance medication safety, empower patients, and streamline clinical workflows. While barriers to widespread adoption persist including variability in health literacy, data integration, and clinician acceptance emerging evidence supports the clinical and operational benefits of PGMH when implemented thoughtfully. Continued research, interdisciplinary collaboration, and adherence to evidence-based guidelines will be essential for realizing the full potential of patient-driven medication histories in optimizing outcomes for complex care populations.